Crossmark

Early evidence of efficacy for orally administered SPM-enriched marine lipid fraction on quality of life and pain in a sample of adults with chronic pain

Crossref DOI link: https://doi.org/10.1186/s12967-020-02569-5

Published Online: 2020-10-21

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Callan, Nini

Hanes, Doug

Bradley, Ryan
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct02683850 at ClinicalTrials.gov

Documents that mention this clinical trial

Early evidence of efficacy for orally administered SPM-enriched marine lipid fraction on quality of life and pain in a sample of adults with chronic pain
https://doi.org/10.1186/s12967-020-02569-5
Funding

Funding for this research was provided by:

Metagenics, Inc.
License Information

Text and Data Mining valid from 2020-10-21

Version of Record valid from 2020-10-21
More Information

Article History

Received: 2 July 2020

Accepted: 12 October 2020

First Online: 21 October 2020

Ethics approval and consent to participate

: The protocol and all study materials were reviewed and approved by the IRB of the National University of Natural Medicine (NUNM; MetaG SPM IRB, #091515-B).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below